Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mabuchi

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 10, 1980
[Serum lipoprotein and LDL pathway in familial hypercholesterolemia (author's transl)]H Mabuchi
Kekkaku : [Tuberculosis]|February 15, 1982
[Studies on the intensification of chemotherapeutic regimen in experimental tuberculosis (author's transl)]H Mabuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 10, 1992
[Hypercholesterolemia]H Mabuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1989
[Recent trend in the research of hyperlipidemia in Japan (2). Molecular genetics and clinical features of familial hypercholesterolemia]H Mabuchi
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1987
Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremiaH Mabuchi, H Nakahashi
Annals of Internal Medicine|September 1, 1994
Omeprazole and diminished antianginal drug deliveryK Kajinami, H Mabuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 9, 2000
[Dyslipidemia in insulin resistance and its improvement by troglitazone]K Yagi, H Mabuchi
Current Opinion in Lipidology|November 11, 1999
Therapeutic effects of LDL apheresis in the prevention of atherosclerosisK Kajinami, H Mabuchi
Clinical Chemistry|April 1, 1983
Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjectsH Mabuchi, H Nakahashi
Therapeutic Drug Monitoring|January 1, 1988
Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serumH Mabuchi, H Nakahashi
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 10, 1980
[Serum lipoprotein and LDL pathway in familial hypercholesterolemia (author's transl)]H Mabuchi
Kekkaku : [Tuberculosis]|February 15, 1982
[Studies on the intensification of chemotherapeutic regimen in experimental tuberculosis (author's transl)]H Mabuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 10, 1992
[Hypercholesterolemia]H Mabuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1989
[Recent trend in the research of hyperlipidemia in Japan (2). Molecular genetics and clinical features of familial hypercholesterolemia]H Mabuchi
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1987
Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremiaH Mabuchi, H Nakahashi
Annals of Internal Medicine|September 1, 1994
Omeprazole and diminished antianginal drug deliveryK Kajinami, H Mabuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 9, 2000
[Dyslipidemia in insulin resistance and its improvement by troglitazone]K Yagi, H Mabuchi
Current Opinion in Lipidology|November 11, 1999
Therapeutic effects of LDL apheresis in the prevention of atherosclerosisK Kajinami, H Mabuchi
Clinical Chemistry|April 1, 1983
Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjectsH Mabuchi, H Nakahashi
Therapeutic Drug Monitoring|January 1, 1988
Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serumH Mabuchi, H Nakahashi
Pageof 30